Performance of plasma free metanephrines in diagnosis of pheochromocytomas and paragangliomas in the population of Asturias

Oleaga, 2008, Pheochromocytoma: diagnostic and therapeutic update, Endocrinol Nutr, 55, 202, 10.1016/S1575-0922(08)70669-7 Lenders, 2017, Update on modern management of pheochromocytoma and paraganglioma, Endocrinol Metab (Seoul), 32, 152, 10.3803/EnM.2017.32.2.152 Lu, 2016, Clinical and pathological characteristics of hypertensive and normotensive adrenal pheochromocytomas, Exp Clin Endocrinol Diabetes, 124, 372, 10.1055/s-0042-100911 Noilhan, 2016, Causes of secondary hypertension in the young population: a monocentric study, Ann Cardiol Angeiol (Paris), 65, 159, 10.1016/j.ancard.2016.04.016 Mannelli, 1999, Pheochromocytoma in Italy: a multicentric retrospective study, Eur J Endocrinol, 141, 619, 10.1530/eje.0.1410619 Timmers, 2007, Clinical presentations, biochemical phenotypes, and genotype–phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas, J Clin Endocrinol Metab, 92, 779, 10.1210/jc.2006-2315 Haissaguerre, 2013, Normotensive incidentally discovered pheochromocytomas display specific biochemical, cellular, and molecular characteristics, J Clin Endocrinol Metab, 98, 4346, 10.1210/jc.2013-1844 Farrugia, 2017, Pheochromocytoma, diagnosis and treatment: review of the literature, Endocr Regul, 51, 168, 10.1515/enr-2017-0018 McNeil, 2000, Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland, Aust N Z J Med, 30, 648, 10.1111/j.1445-5994.2000.tb04358.x Fishbein, 2013, Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing, Ann Surg Oncol, 20, 1444, 10.1245/s10434-013-2942-5 Lenders, 2005, Phaeochromocytoma, Lancet, 366, 665, 10.1016/S0140-6736(05)67139-5 Tabuchi, 2016, Clinical and endocrinological characteristics of adrenal incidentaloma in Osaka region, Japan, Endocr J, 63, 29, 10.1507/endocrj.EJ15-0404 Davison, 2018, Clinical evaluation and treatment of phaeochromocytoma, Ann Clin Biochem, 55, 34, 10.1177/0004563217739931 Lenders, 1995, Plasma metanephrines in the diagnosis of pheochromocytoma, Ann Intern Med, 123, 101, 10.7326/0003-4819-123-2-199507150-00004 Raber, 2000, Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma, Arch Intern Med, 160, 2957, 10.1001/archinte.160.19.2957 Lenders, 2002, New advances in the biochemical diagnosis of pheochromocytoma: moving beyond catecholamines, Ann N Y Acad Sci, 970, 29, 10.1111/j.1749-6632.2002.tb04410.x Christensen, 2011, Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma, Scand J Clin Lab Invest, 71, 695, 10.3109/00365513.2011.622410 Tanaka, 2014, Plasma free metanephrines in the diagnosis of pheochromocytoma: diagnostic accuracy and strategies for Japanese patients, Endocr J, 61, 667, 10.1507/endocrj.EJ13-0277 Lenders, 2014, Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline, J Clin Endocrinol Metab, 99, 1915, 10.1210/jc.2014-1498 Mittendorf, 2007, Pheochromocytoma: advances in genetics, diagnosis, localization, and treatment, Hematol Oncol Clin North Am, 21, 509, 10.1016/j.hoc.2007.04.012 Godfrey, 2001, Pheochromocytoma in a patient with end-stage renal disease, Mayo Clin Proc, 76, 953, 10.1016/S0025-6196(11)62118-6 CLSI, 2008 Fraser, 2001 Ricos, 2004, The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation, Scand J Clin Lab Invest, 64, 175, 10.1080/00365510410004885 Kavinga Gunawardane, 2017, The clinical genetics of phaeochromocytoma and paraganglioma, Arch Endocrinol Metab, 61, 490, 10.1590/2359-3997000000299 Casey, 2017, Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients, Ann Clin Biochem, 54, 170, 10.1177/0004563216646395 Eisenhofer, 2014, Laboratory evaluation of pheochromocytoma and paraganglioma, Clin Chem, 60, 1486, 10.1373/clinchem.2014.224832 Darr, 2017, Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review, Endocrine, 56, 495, 10.1007/s12020-017-1300-y Eisenhofer, 2013, Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma, Ann Clin Biochem, 50, 62, 10.1258/acb.2012.012066